EUVIMEDEUVIMED entdecken
Crossref

HER2 siRNA Facilitated Gene Silencing Coupled with Doxorubicin Delivery: A Dual Responsive Nanoplatform Abrogates Breast Cancer

Archana M G, Anusree K S, Unnikrishnan B S, Reshma P L, Syama H P, Sreekutty J iD, Manu M Joseph iD, Sreelekha T T iD

ACS Applied Materials & Interfaces · 22.05.2024 · 16 (20) · 25710-25726

DOI: 10.1021/acsami.4c02532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 13.05.2024. Verfasst von Archana M G und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre (RCC), Thiruvananthapuram 695011, Kerala, Indi…. Hauptthemen laut MEDLINE: Breast Neoplasms, Doxorubicin, Gene Silencing, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsDoxorubicinGene SilencingErb-b2 Receptor Tyrosine KinasesRNA, Small InterferingAnimalsFemaleHumansMiceApoptosisCell Line, TumorGoldMetal NanoparticlesMice, Inbred BALB CMice, Nude

Stichwörter der Autor:innen

HER2 siRNARNA interferencebreast cancerdoxorubicingene-drug co-delivery

Substanzen

DoxorubicinGoldErb-b2 Receptor Tyrosine KinasesRNA, Small InterferingERBB2 protein, human

Autor:innen und Institutionen

  • Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre (RCC), Thiruvananthapuram 695011, Kerala, India.
  • Centre for Nanotechnology, Indian Institute of Technology (IIT), Roorkee 247667, Uttarakhand, India.
  • Chemical Sciences & Technology Division (CSTD), Organic Chemistry Section, CSIR-National Institute for Interdisciplinary Science & Technology (CSIR-NIIST), Thiruvananthapuram 695019, Kerala, India.
  • Department of Life Sciences, CHRIST University, Banglore 560029, India.

ORCID-Profile: Sreekutty J, Manu M Joseph, Sreelekha T T

Förderung

  • Council of Scientific and Industrial Research, India
  • Science and Engineering Research Board

Zitieren

APA

M G, A., K S, A., B S, U., P L, R., H P, S., J, S., Joseph, M. M., & T T, S. (2024). HER2 siRNA Facilitated Gene Silencing Coupled with Doxorubicin Delivery: A Dual Responsive Nanoplatform Abrogates Breast Cancer. ACS Applied Materials & Interfaces, 16(20), 25710-25726. https://doi.org/10.1021/acsami.4c02532

Vancouver

M G A, K S A, B S U, P L R, H P S, J S, et al. HER2 siRNA Facilitated Gene Silencing Coupled with Doxorubicin Delivery: A Dual Responsive Nanoplatform Abrogates Breast Cancer. ACS Applied Materials & Interfaces. 2024;16(20):25710-25726. doi:10.1021/acsami.4c02532

BibTeX
@article{MG2024,
  author = {M G, Archana and K S, Anusree and B S, Unnikrishnan and P L, Reshma and H P, Syama and J, Sreekutty and Joseph, Manu M and T T, Sreelekha},
  title = {HER2 siRNA Facilitated Gene Silencing Coupled with Doxorubicin Delivery: A Dual Responsive Nanoplatform Abrogates Breast Cancer},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  volume = {16},
  number = {20},
  pages = {25710--25726},
  doi = {10.1021/acsami.4c02532}
}
Kostenlos starten →